Yuriko Otake

Osaka Gakuin University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index216citations50works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(20), Microscopic Colitis(8), Gastrointestinal disorders and treatments(6), Clusterin in disease pathology(5), Gastric Cancer Management and Outcomes(3)

Publications50 total

P0685 A treatment selection model for steroid-refractory Ulcerative Colitis based on two cytokine-responsive serum biomarkers: Leucine-rich α2 glycoprotein and interleukin-22–induced prohaptoglobin
Journal of Crohn s and Colitis·2026
Safety and Effectiveness of Oral Budesonide after Endoscopic Balloon Dilation in Patients with Crohn’s Disease: A Multicenter Prospective Intervention Study
Inflammatory Intestinal Diseases·2025Open Access
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation
Science Immunology·2025· 5 cited
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study
Crohn s & Colitis 360·2025· 2 citedOpen Access
Tu1820: SWITCHING BIOLOGIC AGENTS IN INFLAMMATORY BOWEL DISEASE: THE IMPACT ON TREATMENT SAFETY AND EFFECTIVENESS
Gastroenterology·2025
Leucine-rich Alpha-2 glycoprotein could be clinically useful in active and postoperative Crohn’s disease
Scientific Reports·2025· 5 citedOpen Access
Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching
Scientific Reports·2025· 1 citedOpen Access
P0323 Serum leucine-rich α2-glycoprotein (LRG) and Monocyte chemoattractant protein-1 (MCP-1) as Novel Biomarkers for Predicting Vedolizumab Response in Ulcerative Colitis Patients
Journal of Crohn s and Colitis·2025
Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease
Scientific Reports·2024· 5 citedOpen Access
Sa1779 USEFULNESS OF SERUM LRG AS A BIOMARKER FOR EVALUATING WHOLE COLONIC INFLAMMATION OF ULCERATIVE COLITIS: A MULTICENTER PROSPECTIVE STUDY BY THE OSAKA GUT FORUM
Gastroenterology·2024
Su1804 PRETREATMENT LEVELS OF SERUM LEUCINE-RICH ALPHA-2 GLYCOPROTEIN IS USEFUL FOR SELECTION OF ANTI-CYTOKINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER PROSPECTIVE COHORT STUDY BY THE OSAKA GUT FORUM
Gastroenterology·2024
EP25 SAFETY AND EFFECTIVENESS OF ORAL BUDESONIDE AFTER ENDOSCOPIC BALLON DILATION FOR INTESTINAL STENOSIS IN PATIENTS WITH CROHN'S DISEASE -A MULTICENTER PROSPECTIVE INTERVENTION STUDY
Gastroenterology·2024
P660 Serum Leucine-rich Alpha-2 Glycoprotein Can be a Biomarker for Selecting Anti-Cytokine Biologics in Patients with Inflammatory Bowel Disease: A Multicentre Prospective Cohort Study
Journal of Crohn s and Colitis·2024Open Access
Carbon dioxide insufflation reduces the relapse of ulcerative colitis after colonoscopy: A randomized controlled trial
PLoS ONE·2023· 1 citedOpen Access
EP144 COMBINATION OF IMMUNOMODULATORS WITH USTEKINUMAB IS A VALUABLE OPTION IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Gastroenterology·2023
Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease
PLoS ONE·2023· 4 citedOpen Access
Prokaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases
Cell Genomics·2022· 35 citedOpen Access
Colonoscopy in UC: less pain and reduced recurrence with CO2 insufflation
2022
Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response
The Journal of Experimental Medicine·2022· 38 citedOpen Access
EP1277: EFFICACY OF CARBON DIOXIDE INSUFFLATION DURING COLONOSCOPY FOR PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION -A RANDOMIZED TRIAL-
Gastroenterology·2022Open Access
page 1 of 3Next →

Frequent Co-authors

Takahiro Amano(37), Shinichiro Shinzaki(36), Tetsuo Takehara(36), Hideki Iijima(35), Mizuki Tani(33), Takeo Yoshihara(33), Yoshito Hayashi(30), Yoshiki Tsujii(29), Taku Tashiro(26), Takahiro Inoue(25), Akiko Asakura(17), Satoshi Hiyama(17), Shuko Iwatani(15), Yuko Sakakibara(13), Takuya Yamada(10), Yuri Tsujii(10), Ryotaro Uema(9), Tsutomu Nishida(8), Hiroyuki Ogawa(8), Naoto Osugi(7)